These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 4947731
41. [Local hypothermia in the correction of motor and speech disorders in children with cerebral palsy]. Stepanchenko OV. Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(8):22-5. PubMed ID: 2175111 [Abstract] [Full Text] [Related]
42. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. Hawamdeh ZM, Ibrahim AI, Al-Qudah AA. Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388 [Abstract] [Full Text] [Related]
43. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Gibson N, Graham HK, Love S. Disabil Rehabil; 2007 Dec 15; 29(23):1813-22. PubMed ID: 18033606 [Abstract] [Full Text] [Related]
44. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy. Boćkowski L, Okurowska-Zawada B, Sobaniec W, Kułak W, Sendrowski K. Adv Med Sci; 2007 Dec 15; 52 Suppl 1():171-5. PubMed ID: 18229658 [Abstract] [Full Text] [Related]
46. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study. Scheinberg A, Hall K, Lam LT, O'Flaherty S. J Paediatr Child Health; 2006 Nov 15; 42(11):715-20. PubMed ID: 17044900 [Abstract] [Full Text] [Related]
47. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients. Papadonikolakis AS, Vekris MD, Korompilias AV, Kostas JP, Ristanis SE, Soucacos PN. Acta Orthop Scand; 2003 Dec 15; 74(6):749-55. PubMed ID: 14763710 [Abstract] [Full Text] [Related]
49. A controlled study of methocarbamol (Robaxin) in acute painful musculoskeletal conditions. Tisdale SA, Ervin DK. Curr Ther Res Clin Exp; 1975 Jun 15; 17(6):525-30. PubMed ID: 808374 [No Abstract] [Full Text] [Related]
50. Evaluation of diazepam in skeletal muscle hypertonicity in cerebral palsy. Carter CH. Arch Phys Med Rehabil; 1968 Sep 15; 49(9):519-23. PubMed ID: 4877069 [No Abstract] [Full Text] [Related]
51. Medical treatment for spasticity in children with cerebral palsy. Nogen AG. Childs Brain; 1976 Sep 15; 2(5):304-8. PubMed ID: 798660 [Abstract] [Full Text] [Related]
52. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society. Whelan MA, Delgado MR. Neurology; 2010 Aug 17; 75(7):669. PubMed ID: 20713958 [No Abstract] [Full Text] [Related]
53. A controlled trial of baclofen in children with cerebral palsy. Milla PJ, Jackson AD. J Int Med Res; 1977 Aug 17; 5(6):398-404. PubMed ID: 338390 [Abstract] [Full Text] [Related]
54. The frequency of other handicaps in children with cerebral palsy. Robinson RO. Dev Med Child Neurol; 1973 Jun 17; 15(3):305-12. PubMed ID: 4198049 [No Abstract] [Full Text] [Related]
57. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Joynt RL, Leonard JA. Dev Med Child Neurol; 1980 Dec 17; 22(6):755-67. PubMed ID: 7004956 [Abstract] [Full Text] [Related]
60. Neurorehabilitation of children with cerebral palsy. Maria Barlow K. Handb Clin Neurol; 2008 Dec 17; 87():591-609. PubMed ID: 18809046 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]